Cargando…

Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study

BACKGROUND: Our previous work has demonstrated the benefits of transcutaneous immunization in targeting Langerhans cells and preferentially inducing CD8 T-cell responses. METHODS: In this randomized phase Ib clinical trial including 20 HIV uninfected volunteers, we compared the safety and immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanchez, Jorge, Gonçalves, Elena, Llano, Anuska, Gonzáles, Pedro, Fernández-Maldonado, María, Vogt, Annika, Soria, Angele, Perez, Susana, Cedeño, Samandhy, Fernández, Marco Antonio, Nourikyan, Julien, de Bernard, Simon, Ganoza, Carmela, Pedruzzi, Eric, Bonduelle, Olivia, Mothe, Beatriz, Gòmez, Carmen E., Esteban, Mariano, Garcia, Felipe, Lama, Javier R., Brander, Christian, Combadiere, Behazine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683801/ https://www.ncbi.nlm.nih.gov/pubmed/33244316 http://dx.doi.org/10.3389/fimmu.2020.586124

Ejemplares similares

Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
por: Olvera, Alex, et al.
Publicado: (2021)

Virological, Immune and Host genetics Markers in the Control of HIV Infection
por: Mothe, Beatriz, et al.
Publicado: (2009)

Host Transcriptome and Microbiota Signatures Prior to Immunization Profile Vaccine Humoral Responsiveness
por: Gonçalves, Elena, et al.
Publicado: (2021)

Original Encounter with Antigen Determines Antigen-Presenting Cell Imprinting of the Quality of the Immune Response in Mice
por: Abadie, Valérie, et al.
Publicado: (2009)

Strategies for Immunomonitoring after Vaccination and during Infection
por: Adam, Lucille, et al.
Publicado: (2021)

Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B
por: Couto, Elvira, et al.
Publicado: (2019)

Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation
por: Bonduelle, Olivia, et al.
Publicado: (2022)

Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
por: Oriol-Tordera, Bruna, et al.
Publicado: (2022)

Quantum vaccinomics platforms to advance in vaccinology
por: de la Fuente, José, et al.
Publicado: (2023)

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART
por: Gómez, Carmen Elena, et al.
Publicado: (2015)

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells
por: Ternette, Nicola, et al.
Publicado: (2015)

Immunoinformatics and reverse vaccinomic approaches for effective design
por: Parihar, Arpana, et al.
Publicado: (2022)

In vivo Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical Trial
por: Rosás-Umbert, Miriam, et al.
Publicado: (2020)

Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller
por: Pernas, María, et al.
Publicado: (2012)

New challenges in modern vaccinology
por: Centlivre, Mireille, et al.
Publicado: (2015)

Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control
por: Oriol-Tordera, Bruna, et al.
Publicado: (2020)

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions
por: Llano, Anuska, et al.
Publicado: (2013)

Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii
por: ud-din, Miraj, et al.
Publicado: (2022)

Vaccinomics to Design a Multiepitope Vaccine against Legionella pneumophila
por: Umar, Ahitsham, et al.
Publicado: (2022)

A Quantum Vaccinomics Approach for the Design and Production of MSP4 Chimeric Antigen for the Control of Anaplasma phagocytophilum Infections
por: de la Fuente, José, et al.
Publicado: (2022)

CD8(+)PD-L1(+)CXCR3(+) polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2–infected patients
por: Adam, Lucille, et al.
Publicado: (2021)

Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial
por: Combadière, Behazine, et al.
Publicado: (2010)

Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and Anaplasma phagocytophilum Infection
por: Contreras, Marinela, et al.
Publicado: (2017)

Identification of Interleukin-27 (IL-27)/IL-27 Receptor Subunit Alpha as a Critical Immune Axis for In Vivo HIV Control
por: Ruiz-Riol, M., et al.
Publicado: (2017)

Ethical and policy implications of vaccinomics in the United States: community members’ perspectives
por: Gerber, Jennifer E., et al.
Publicado: (2021)

Acquired immune responses to the seasonal trivalent influenza vaccination in COPD
por: Staples, K. J., et al.
Publicado: (2019)

P12-09. Immune responses in controlled and uncontrolled HIV infection to a designed HIV immunogen sequence focused on conserved regions of the viral genome
por: Mothe, B, et al.
Publicado: (2009)

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice
por: Saubi, Narcís, et al.
Publicado: (2020)

Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
por: Pooley, Nick, et al.
Publicado: (2023)

Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach
por: Shantier, Shaza W., et al.
Publicado: (2022)

Peptide-Based Vaccination for Antibody Responses Against HIV
por: Combadière, Behazine, et al.
Publicado: (2019)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
por: Rosás-Umbert, Miriam, et al.
Publicado: (2017)

Novel Nested Peptide Epitopes Recognized by CD4(+) T Cells Induced by HIV-1 Conserved-Region Vaccines
por: Borthwick, Nicola, et al.
Publicado: (2020)

Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers
por: Rosás-Umbert, Miriam, et al.
Publicado: (2019)

Newborn Mice Vaccination with BCG.HIVA(222) + MVA.HIVA Enhances HIV-1-Specific Immune Responses: Influence of Age and Immunization Routes
por: Saubi, Narcís, et al.
Publicado: (2011)

Implementation of Vaccinomics and In-Silico Approaches to Construct Multimeric Based Vaccine Against Ovarian Cancer
por: Sufyan, Muhammad, et al.
Publicado: (2021)

Translational vaccinomics and structural filtration algorithm to device multiepitope vaccine for catastrophic monkeypox virus
por: Singh, Satyendra, et al.
Publicado: (2023)

A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
por: Mothe, Beatriz, et al.
Publicado: (2015)

Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy In Vitro
por: Olvera, Alex, et al.
Publicado: (2018)

Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice
por: Gao, Feixia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_33pp6fhfp9ok5lhmicctqfn3m0